ONCOCLINICAS (ONCO3) Main Indicators
Basic Data - ONCO3
Company | ONCOCLINICAS |
Corporate Name | ONCOCLINICAS DO BRASIL SERVICOS MEDICOS S.A. |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Exploração de serviços médicos. participação em outras sociedades. nacionais ou estrangeiras. pesquisa e desenvolvimento experimental em ciências físicas e naturais. intermediação em pesquisa clínica. |
Share | ONCO3 |
Quote Date | 09/18/2024 |
Share Type | ON |
Last Closing | R$ 5.59 |
Quotation Factor | 1 Share |
Financial Volume | R$ 16.29 M |
Last Statement | ITR - 06/30/2024 |
Sector | Saúde |
Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
Updated 09/19/2024 |
Relative Prices - ONCO3
Price/Earnings | 18.94 |
Price/SBV | 0.96 |
Price/Net Sales | 0.62 |
Price/CFO | -11.74 |
Price/FCF | -5.93 |
Price/Total Assets | 0.30 |
Price/EBIT | 4.90 |
Price/Working Capital | 1.48 |
Price/NCAV | -0.62 |
EV/EBIT | 11.66 |
EV/EBITDA | 8.54 |
EV/Net Sales | 1.48 |
EV/CFO | -27.96 |
EV/FCF | -14.12 |
EV/Total Assets | 0.72 |
Company Market Cap | R$ 3.64 B |
Enterprise Value | R$ 8.67 B |
Current Financial Statement Date | 06/30/2024 |
Current Share Price | R$ 5.59 |
Share Price Date | 09/18/2024 |
Dividend Yield | 0.00% |
Updated 09/19/2024 |
Income Statement - ONCO3
Net Revenue | R$ 5.86 B |
Gross Result | R$ 1.99 B |
EBIT | R$ 743.69 M |
Depreciation and Amortization | - R$ 271.79 M |
EBITDA | R$ 1.02 B |
Net Profit | R$ 192.32 M |
Net Profit/Share | R$ 0.36 |
Updated 08/13/2024 |
Net Revenue | R$ 1.57 B |
Gross Result | R$ 526.97 M |
EBIT | R$ 215.22 M |
Depreciation and Amortization | - R$ 69.73 M |
EBITDA | R$ 284.96 M |
Net Profit | R$ 3.30 M |
Profit/Share | R$ 0.01 |
Updated 08/13/2024 |
Price and Volume Behavior - ONCO3
Lowest Price 52 weeks | R$ 5.20 |
Highest Price 52 weeks | R$ 13.00 |
Variation 2024 | -55.28% |
Variation 1 year | -51.93% |
Variation 2 years(total) | -17.55% |
Variation 2 years(yearly) | -9.16% |
Variation 3 years(total) | -62.71% |
Variation 3 years(yearly) | -27.98% |
Variation 4 years(total) | - |
Variation 4 years(yearly) | - |
Variation 5 years(total) | - |
Variation 5 years(yearly) | - |
Average Daily Volume (3 months) | R$ 28.57 M |
Updated 09/19/2024 |
Returns and Margins - ONCO3
Return on Initial Tangible Capital | 18.84% |
Return on Initial Invested Capital | 9.23% |
Pre-Tax Return on Initial Tangible Capital | 28.55% |
Pre-Tax Return on Initial Invested Capital | 13.99% |
Return on Initial Shareholder´s Equity | 8.62% |
Return on Initial Asset | 2.25% |
Gross Margin | 33.98% |
Net Margin | 3.28% |
EBIT Margin | 12.69% |
EBITDA Margin | 17.32% |
Initial Asset Turnover | 0.69 |
Financial Leverage | 3.18 |
Liabilities/Net Worth | 2.18 |
Net Debt/EBITDA | 4.95 |
Updated 08/13/2024 |
Balance Sheet - ONCO3
Cash and Cash Equivalents | R$ 550.59 M |
Total Assets | R$ 12.11 B |
Short-Term Debt | R$ 928.26 M |
Long-Term Debt | R$ 4.65 B |
Gross Debt | R$ 5.58 B |
Net Debt | R$ 5.03 B |
Shareholder´s Equity | R$ 3.81 B |
Share Book Value | R$ 7.23 |
Common Shares | 527,481,598 |
Preferred Shares | 0 |
Total | 527,481,598 |
Common Shares in Treasury | 19,076,007 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 19,076,007 |
Common Shares (Except Treasury) | 508,405,591 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 508,405,591 |
Updated 08/13/2024 |
Cash Flow - ONCO3
Operating Cash Flow | - R$ 310.23 M |
Cash Flow from Investments | - R$ 2.13 B |
Financing Cash Flow | R$ 2.44 B |
Increase (Reduction) in Cash and Equivalents | R$ 163.00 thousand |
Updated 08/13/2024 |
Operating Cash Flow | - R$ 196.37 M |
Cash Flow from Investments | - R$ 1.82 B |
Financing Cash Flow | R$ 2.16 B |
Increase (Reduction) in Cash and Equivalents | R$ 137.82 M |
Updated 08/13/2024 |
Experimental - ONCO3
CAPEX 3 months | - R$ 76.63 M |
Free Cash Flow 3 months | - R$ 273.00 M |
CAPEX 12 months | - R$ 303.86 M |
Free Cash Flow 12 months | - R$ 614.09 M |
Updated 08/13/2024 |